These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 2150753

  • 21. A role for Ras in v-Crk transformation.
    Greulich H, Hanafusa H.
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
    Kaplan JB.
    Oncol Res; 1994 Nov; 6(12):611-5. PubMed ID: 7787254
    [Abstract] [Full Text] [Related]

  • 29. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y, Nakano S, Ueno H, Niho Y.
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 32. C127 cells resistant to transformation by tyrosine protein kinase oncogenes.
    Cuadrado A, Talbot N, Barbacid M.
    Cell Growth Differ; 1990 Jan; 1(1):9-15. PubMed ID: 2150330
    [Abstract] [Full Text] [Related]

  • 33. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP.
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [Abstract] [Full Text] [Related]

  • 34. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D, Fischberg-Bender E, Heimer EP, Felix A, Skalka AM.
    Cancer Res; 1989 Nov 15; 49(22):6425-31. PubMed ID: 2680065
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 39. A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.
    Kato J, Sherr CJ.
    Oncogene; 1991 May 01; 6(5):687-93. PubMed ID: 2052353
    [Abstract] [Full Text] [Related]

  • 40. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC, Prorock-Rogers C, Kelly J, Dong Z, Lin JJ, Armstrong L, Kung HF, Weber MJ, Afonso A.
    Cancer Res; 1995 Nov 01; 55(21):5106-17. PubMed ID: 7585559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.